Junia C. Costa

826 total citations
24 papers, 593 citations indexed

About

Junia C. Costa is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Junia C. Costa has authored 24 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Oncology. Recurrent topics in Junia C. Costa's work include Medical Imaging Techniques and Applications (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). Junia C. Costa is often cited by papers focused on Medical Imaging Techniques and Applications (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). Junia C. Costa collaborates with scholars based in Denmark, Sweden and United Kingdom. Junia C. Costa's co-authors include Per Munck af Rosenschöld, Ian Law, Svend Aage Engelholm, Anne Kiil Berthelsen, Jens Benn Sørensen, Eric Santoni‐Rugiu, Linea Cecilie Melchior, Annika Loft, Hans Skovgaard Poulsen and Michael Lundemann and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and The Oncologist.

In The Last Decade

Junia C. Costa

24 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junia C. Costa Denmark	14	222	200	156	130	126	24	593
Berna Akkuş Yıldırım Türkiye	13	94 0.4×	183 0.9×	121 0.8×	41 0.3×	57 0.5×	64	484
Silke Engelholm Sweden	17	297 1.3×	331 1.7×	69 0.4×	157 1.2×	161 1.3×	37	773
Kelly Stuhr United States	15	196 0.9×	382 1.9×	122 0.8×	194 1.5×	39 0.3×	25	660
Anne Ducassou France	14	62 0.3×	259 1.3×	93 0.6×	109 0.8×	40 0.3×	69	560
Goura Kisor Rath India	13	99 0.4×	109 0.5×	291 1.9×	89 0.7×	75 0.6×	33	605
Hyun‐Cheol Kang South Korea	14	157 0.7×	153 0.8×	120 0.8×	112 0.9×	38 0.3×	54	626
Yoshihito Nomoto Japan	15	85 0.4×	211 1.1×	81 0.5×	79 0.6×	38 0.3×	49	532
Brian J. Gebhardt United States	10	73 0.3×	145 0.7×	55 0.4×	144 1.1×	36 0.3×	21	360
D. Delishaj Italy	11	92 0.4×	144 0.7×	67 0.4×	104 0.8×	34 0.3×	35	447
Anupama Chundury United States	11	79 0.4×	160 0.8×	98 0.6×	39 0.3×	60 0.5×	39	356

Countries citing papers authored by Junia C. Costa

Since Specialization

Citations

This map shows the geographic impact of Junia C. Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junia C. Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junia C. Costa more than expected).

Fields of papers citing papers by Junia C. Costa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junia C. Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junia C. Costa. The network helps show where Junia C. Costa may publish in the future.

Co-authorship network of co-authors of Junia C. Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Junia C. Costa. A scholar is included among the top collaborators of Junia C. Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junia C. Costa. Junia C. Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grauslund, Morten, et al.. (2024). ALK-tyrosine kinase inhibitor intrinsic resistance due to de novo MET-amplification in metastatic ALK-rearranged non-small cell lung cancer effectively treated by alectinib-crizotinib combination—case report. Translational Lung Cancer Research. 13(9). 2453–2462. 1 indexed citations

Grauslund, Morten, Johan Löfgren, Junia C. Costa, et al.. (2023). Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR-Mutated NSCLC. International Journal of Molecular Sciences. 24(17). 13077–13077. 5 indexed citations

Costa, Junia C., Jens Christian Nørgaard, Bastian Neesgaard, et al.. (2022). Chest x-ray imaging score is associated with severity of COVID-19 pneumonia: the MBrixia score. Scientific Reports. 12(1). 21019–21019. 4 indexed citations

Sørensen, Jens Benn, et al.. (2020). Changing ALK-TKI-Resistance Mechanisms in Rebiopsies of ALK-Rearranged NSCLC: ALK- and BRAF-Mutations Followed by Epithelial-Mesenchymal Transition. International Journal of Molecular Sciences. 21(8). 2847–2847. 25 indexed citations

Lundemann, Michael, Junia C. Costa, Ian Law, et al.. (2017). Patterns of failure for patients with glioblastoma following O-(2-[ 18 F]fluoroethyl)- L -tyrosine PET- and MRI-guided radiotherapy. Radiotherapy and Oncology. 122(3). 380–386. 23 indexed citations

Rechner, Laura Ann, Ane Appelt, Anne Kiil Berthelsen, et al.. (2017). Metal artefact reduction for accurate tumour delineation in radiotherapy. Radiotherapy and Oncology. 126(3). 479–486. 38 indexed citations

Møller, Søren, Per Munck af Rosenschöld, Junia C. Costa, et al.. (2017). Toxicity and efficacy of re-irradiation of high-grade glioma in a phase I dose- and volume escalation trial. Radiotherapy and Oncology. 125(2). 223–227. 19 indexed citations

Santoni‐Rugiu, Eric, et al.. (2017). Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3 -mutation, localized transformation to EGFR -mutated SCLC, and acquired T790M EGFR -mutation. Lung Cancer. 113. 14–17. 18 indexed citations

Costa, Junia C., et al.. (2016). PO-0651: Pattern of failure in glioblastoma patients after FET-PET and MRI-guided chemo-radiotherapy. Radiotherapy and Oncology. 119. S304–S304. 1 indexed citations

10.

Rasmussen, Jacob H., Martin Nørgaard, Adam E. Hansen, et al.. (2016). Feasibility of Multiparametric Imaging with PET/MR in Head and Neck Squamous Cell Carcinoma. Journal of Nuclear Medicine. 58(1). 69–74. 40 indexed citations

11.

Møller, Søren, Ian Law, Per Munck af Rosenschöld, et al.. (2016). Prognostic value of 18F-FET PET imaging in re-irradiation of high-grade glioma: Results of a phase I clinical trial. Radiotherapy and Oncology. 121(1). 132–137. 29 indexed citations

12.

Costa, Junia C., et al.. (2015). A Case of Asymptomatic Venous Air Embolism Demonstrated on 18F FDG PET/CT. Clinical Nuclear Medicine. 41(5). 385–386. 2 indexed citations

13.

Jakobsen, Jakob Kristian, Junia C. Costa, Peter Sommer, et al.. (2015). DaPeCa‐3: promising results of sentinel node biopsy combined with ¹⁸ F‐fluorodeoxyglucose positron emission tomography/computed tomography in clinically lymph node‐negative patients with penile cancer – a national study from Denmark. British Journal of Urology. 118(1). 102–111. 31 indexed citations

14.

Hofland, Kenneth Francis, Steinbjørn Hansen, Morten Mau‐Sørensen, et al.. (2014). Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study. Acta Oncologica. 53(7). 939–944. 24 indexed citations

15.

Rosenschöld, Per Munck af, Junia C. Costa, Svend Aage Engelholm, et al.. (2014). Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma. Neuro-Oncology. 17(5). 757–763. 45 indexed citations

16.

Antonsen, Sofie Leisby, Lisa Neerup Jensen, Ann Tabor, et al.. (2014). MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer - a multicenter prospective comparative study. VBN Forskningsportal (Aalborg Universitet). 6 indexed citations

17.

Møller, Søren, Michael Lundemann, Per Munck af Rosenschöld, et al.. (2014). RT-22 * MRI AND FET PET FOR RADIOTHERAPY PLANNING IN RECURRENT HIGH-GRADE GLIOMA (HGG) IN A PROSPECTIVE PHASE I TRIAL. Neuro-Oncology. 16(suppl 5). v192–v192. 1 indexed citations

18.

Grauslund, Morten, Linea Cecilie Melchior, Junia C. Costa, et al.. (2013). Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report. BMC Research Notes. 6(1). 489–489. 37 indexed citations

19.

Antonsen, Sofie Leisby, Lisa Neerup Jensen, Annika Loft, et al.. (2012). MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer — A multicenter prospective comparative study. Gynecologic Oncology. 128(2). 300–308. 164 indexed citations

20.

Møller, Anne Kirstine Hundahl, Annika Loft, Anne Kiil Berthelsen, et al.. (2012). A Prospective Comparison of 18F-FDG PET/CT and CT as Diagnostic Tools to Identify the Primary Tumor Site in Patients with Extracervical Carcinoma of Unknown Primary Site. The Oncologist. 17(9). 1146–1154. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact